BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBNSINA

All Eps Dividend Board Agm Q1 Q2 Q3

IBNSINA 25-Apr-2021

(Q3 Un-audited): EPS was Tk. 2.79 for January-March 2021 as against Tk. 2.33 for January-March 2020; EPS was Tk. 10.92 for July 2020-March 2021 as against Tk. 9.63 for July 2019-March 2020. NOCFPS was Tk. 14.17 for July 2020-March 2021 as against Tk. 9.54 for July 2019-March 2020. NAV per share was Tk. 64.08 as on March 31, 2021 and Tk. 56.88 as on June 30, 2020.

IBNSINA 18-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 24, 2021 at 12:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

IBNSINA 05-Apr-2021

IBN SINA TRUST, one of the Corporate Sponsor Directors of the Company, has further reported that it has completed its buying of 1,00,000 shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on 04.03.2021.

IBNSINA 04-Mar-2021

IBN SINA TRUST, one of the Corporate Sponsor Directors of the Company, has expressed its intention to buy 1,00,000 shares of the Company at prevailing market price (In the Public market) through Stock Exchange (DSE) within next 30 working days, as per Rule-4 of the BSEC (Substantial Acquisition of shares and Takeovers), Rules, 2018.

IBNSINA 24-Jan-2021

(Q2 Un-audited): Consolidated EPS was Tk. 4.95 for October-December 2020 whereas (Solo) Tk. 4.43 for October-December 2019; Consolidated EPS was Tk. 8.19 for July-December 2020 whereas (Solo) Tk. 7.30 for July-December 2019. Consolidated NOCFPS was Tk. 10.48 for July-December 2020 whereas (Solo) Tk. 3.69 for July-December 2019. Consolidated NAV per share was Tk. 61.23 as on December 31, 2020 and Tk. 56.88 as on June 30, 2020.

IBNSINA 19-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 23, 2021 at 12:00 Noon to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

IBNSINA 03-Jan-2021

(Continuation news of IBNSINA): where the Board also approved Authorized and paid up capital of the Subsidiary Company respectively BDT 40.00 crore and BDT 12.00 crore. (end)

IBNSINA 03-Jan-2021

The Company has informed that the Board of Directors has decided to form a Subsidiary Company in the name of The IBN Sina Natural Medicine Ltd. aiming to comply with the legal requirements of the Directorate General of Drug Administration (DGDA), Government of Bangladesh under wholly owned investment of The IBN SINA Pharmaceutical Industry Ltd. subject to completion of all regulatory formalities and approval of the concerned regulatory authorities, (cont.)

IBNSINA 21-Dec-2020

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2020 to the respective shareholders through BEFTN, Banking Channel and Registered courier as per rule.

IBNSINA 10-Dec-2020

PANACEA SERVICES (PVT.) LTD. (where Ibn Sina Trust is the shareholder of PANACEA SERVICES (PVT.) LTD. and also a Corporate Sponsor of The IBN SINA Pharmaceutical Industry Ltd.), has further reported that it has completed its buying of 100,000 shares of the Company at prevailing market price through Stock Exchange as per declaration disseminated on 17.11.2020.

Previous Next page